Inovio signs deal with Japan’s Kaneka for COVID-19 vaccine manufacturing
Inovio has also signed manufacturing deals with medical device maker Thermo Fisher Scientific among others
Japan’s Kaneka Corp has entered into a deal to manufacture Inovio Pharmaceuticals’ COVID-19 vaccine candidate, informed the company.
It did not disclose the terms of the agreement with Kaneka Eurogentec, a unit of the Japanese chemical company.
Inovio has also signed manufacturing deals with medical device maker Thermo Fisher Scientific among others, to increase the supply of the vaccine, which entered a mid-stage study last month.
The Phase 3 of the mid-to-late stage study is under a partial hold by the US Food and Drug Administration as it seeks more information, including details on a delivery device used to inject genetic material into cells.
(Edits by EP News Bureau)
- Advertisement -